제약용 천연 전분 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 8.9%의 CAGR로 86억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장의 원동력은 제약 혁신에 대한 투자 증가, 지속가능한 조달에 대한 집중 강화, 새로운 제형 사용 증가, 클린 라벨 의약품에 대한 수요 증가, 신흥 시장에서의 헬스케어 지출 증가 등입니다. 예측 기간의 주요 동향으로는 전분 가공 기술 발전, 약물전달 시스템 혁신, 바이오 기반 의약품 원료 개발, 식물 유래 부형제 연구 개발, 용해도 및 안정성 솔루션의 발전 등이 있습니다.
만성질환의 유병률 증가는 향후 몇 년 동안 제약용 천연 전분 시장의 성장을 촉진할 것으로 예상됩니다. 만성질환은 일반적으로 서서히 발병하고 1년 이상 지속되는 장기적인 질병입니다. 만성질환의 증가는 인구의 고령화가 주요 원인이며, 고령자는 당뇨병, 심혈관질환, 관절염, 암과 같은 장기적인 건강 문제에 걸리기 쉬우며, 이는 나이가 들면서 유행하기 쉽기 때문입니다. 의약품 원료 전분은 약물 제제의 안정성을 높이고, 생체 이용률을 높이고, 약물 방출을 조절하고, 환자의 순응도를 높이고, 궁극적으로 만성질환의 효과와 장기적인 관리를 지원함으로써 만성질환의 관리에 중요한 역할을 합니다. 예를 들어, 2024년 6월 호주 보건 복지 연구소는 만성질환으로 인한 사망률이 증가하여 2021년 인구 10만 명당 459명에서 2022년 490명으로 증가할 것이라고 보고했습니다. 이에 따라 만성질환의 유병률 증가는 의약품 원료 전분 시장의 성장을 견인하고 있습니다.
제약용 천연 전분 시장의 기업들은 제형화 및 환자 순응도를 개선하기 위해 식물성 텍스처와 같은 혁신적인 제품 개발에 주력하고 있습니다. 식물 유래 텍스처는 두께, 겔 강도 등 식물 유래 성분의 물리적 특성을 의미하며, 보다 효과적인 천연물 의약품 제제를 위해 정제의 결합성, 붕괴성, 입맛을 개선하여 의약품에서 생전분의 성능을 향상시키는 데 도움이 됩니다. 예를 들어, 2024년 2월 미국 식품 회사 인 Ingredion Incorporated는 유제품 및 대체 유제품의 질감과 안정성을 개선하기 위해 고안된 클린 라벨 텍스처 라이저 인 Novation Indulge 2940 전분을 출시했습니다. 이 혁신적인 제약 원료 전분은 의약품의 성능, 생체 이용률 및 방출 제어를 향상시키는 기능적 이점을 제공함과 동시에 청정 라벨의 지속가능한 제품 개발을 지원합니다. NOVATION Indulge 2940 전분은 클린 라벨 천연 원료를 사용하여 유제품 및 대체 유제품의 질감, 안정성 및 소비자 수용성을 개선합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 제약용 천연 전분 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 제약용 천연 전분 시장 : 성장률 분석
- 세계의 제약용 천연 전분 시장 실적 : 규모와 성장, 2019-2024
- 세계의 제약용 천연 전분 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 제약용 천연 전분 전체 시장(TAM)
제6장 시장 세분화
- 세계의 제약용 천연 전분 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 감자 전분
- 옥수수 전분
- 기타 유형
- 세계의 제약용 천연 전분 시장 : 제형 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 경구 고형제
- 액체 제형
- 국소 제제
- 주사제
- 제어 방출 제제
- 세계의 제약용 천연 전분 시장 : 기능별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 텍스처링제
- 보습제
- 증량제
- 유화제
- 필름 형성제
- 세계의 제약용 천연 전분 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 바인더와 코팅제
- 붕괴제
- 충전제와 증량제
- 안정제
- 증점제
- 세계의 제약용 천연 전분 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 제약 제조업체
- 수탁연구기관(Cros)
- 수탁제조기관(CMOS)
- 연구개발 실험실
- 학술기관
- 기타 최종사용자
- 세계의 제약용 천연 전분 시장, 감자 전분 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 가공 감자 전분
- 천연 감자 전분
- 세계의 제약용 천연 전분 시장, 옥수수 전분 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 가공 옥수수 전분
- 천연 옥수수 전분
- 세계의 제약용 천연 전분 시장, 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 쌀 전분
- 밀 전분
- 타피오카 전분
제7장 지역별·국가별 분석
- 세계의 제약용 천연 전분 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 제약용 천연 전분 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 제약용 천연 전분 시장 : 경쟁 구도
- 제약용 천연 전분 시장 : 기업 개요
- Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
- Archer Daniels Midland Company Overview, Products and Services, Strategy and Financial Analysis
- Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis
- Tereos SCA Overview, Products and Services, Strategy and Financial Analysis
- Roquette Freres SA. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- AGRANA
- Tate & Lyle Public Limited Company
- Colorcon Inc.
- Grain Processing Corporation
- Siam Modified Starch Co. Ltd.
- BENEO GmbH
- Gulshan Polyols Ltd.
- SPAC Starch Products(India) Private Limited
- Universal Starch-Chem Allied Ltd.
- Sanstar Biopolymers Ltd.
- Emsland Group
- Hungrana Kft.
- Bluecraft Agro Pvt. Ltd.
- Visco Starch
- Shandong Liujia Pharmaceutical Excipient Co.Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 제약용 천연 전분 시장 2029 : 새로운 기회를 제공하는 국가
- 제약용 천연 전분 시장 2029 : 새로운 기회를 제공하는 부문
- 제약용 천연 전분 시장 2029 : 성장 전략
제36장 부록
ksm
Pharmaceutical native starch is a natural, unmodified starch sourced from plants such as corn, potato, wheat, or tapioca, and is used as an excipient in pharmaceutical formulations. It serves various purposes such as acting as a binder, disintegrant, or filler in tablets and capsules, playing a key role in regulating medication release, enhancing stability, and ensuring proper tablet formation, all without the need for chemical or physical alteration.
The primary types of pharmaceutical native starches include potato starch, corn starch, and others. Potato starch, a fine white powder extracted from potato tubers, is recognized for its smooth texture and superior binding capabilities, making it well-suited for pharmaceutical tablet formulations. It is available in various formulation types, including oral solids, liquids, topical products, injectables, and controlled-release formulations. Its versatility allows it to function as a texturizer, moisture-retaining agent, bulking agent, emulsifier, and film-former. It is commonly used as a binder, coating agent, disintegrant, filler, stabilizer, and thickener, serving a wide range of end-users such as pharmaceutical manufacturers, contract research organizations (CROs), contract manufacturing organizations (CMOs), research and development labs, academic institutions, and more.
The pharmaceuticals native starch market research report is one of a series of new reports from The Business Research Company that provides pharmaceuticals native starch market statistics, including pharmaceuticals native starch industry global market size, regional shares, competitors with a pharmaceuticals native starch market share, pharmaceuticals native starch market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceuticals native starch industry. This pharmaceuticals native starch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmaceuticals native starch market size has grown strongly in recent years. It will grow from $5.65 billion in 2024 to $6.17 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth observed in the past can be linked to a higher demand for natural excipients, increased pharmaceutical production, a growing preference for biocompatible ingredients, the expansion of generic drug manufacturing, and greater regulatory backing for natural ingredients.
The pharmaceuticals native starch market size is expected to see strong growth in the next few years. It will grow to $8.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth expected in the forecast period is driven by rising investments in pharmaceutical innovation, a stronger focus on sustainable sourcing, the growing use of novel drug formulations, an increasing demand for clean-label pharmaceutical products, and higher healthcare spending in emerging markets. Key trends in the forecast period include advancements in starch processing technology, innovations in drug delivery systems, developments in bio-based pharmaceutical ingredients, ongoing research in plant-based excipients, and progress in solubility and stability solutions.
The growing prevalence of chronic diseases is expected to drive the expansion of the pharmaceutical native starch market in the coming years. Chronic diseases are long-term medical conditions that typically develop gradually and last for over a year. The rise in chronic diseases is largely due to an aging population, as older individuals are more prone to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more prevalent with age. Pharmaceutical native starch plays a significant role in managing chronic diseases by enhancing the stability of drug formulations, improving bioavailability, enabling controlled drug release, promoting patient adherence, and ultimately supporting the effectiveness and long-term management of chronic conditions. For example, in June 2024, the Australian Institute of Health and Welfare reported an increase in the death rate from chronic diseases, rising from 459 per 100,000 people in 2021 to 490 per 100,000 in 2022. As a result, the growing prevalence of chronic diseases is fueling the growth of the pharmaceutical native starch market.
Companies in the pharmaceutical native starch market are focusing on developing innovative products, such as plant-based textures, to improve drug formulation and patient compliance. Plant-based textures refer to the physical properties of plant-derived ingredients, such as thickness and gel strength, which help enhance the performance of native starch in pharmaceuticals by improving tablet binding, disintegration, and mouthfeel for more effective natural drug formulations. For example, in February 2024, Ingredion Incorporated, a U.S.-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to improve texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional benefits that enhance drug formulation performance, bioavailability, and controlled release, while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.
In September 2022, Roquette Freres, a France-based food company, acquired Crest Cellulose for an undisclosed sum. This acquisition aims to strengthen Roquette's position in the pharmaceutical excipients market by expanding its range of plant-based, pharmacopoeia-compliant solutions and meeting the growing demand for high-quality drug delivery ingredients, particularly in India and the Asia Pacific region. Crest Cellulose, an India-based manufacturer, specializes in producing pregelatinized starch and sodium starch glycolate.
Major players in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Freres SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, and Shandong Liujia Pharmaceutical Excipient Co.Ltd.
North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceuticals native starch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pharmaceuticals native starch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharmaceuticals native starch market consists of sales of sorghum starch, barley starch, sweet potato starch, and arrowroot starch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmaceuticals Native Starch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pharmaceuticals native starch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pharmaceuticals native starch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceuticals native starch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Potato Starch; Corn Starch; Other Types
- 2) By Formulation Type: Oral Solid Dosage Forms; Liquid Dosage Forms; Topical Formulations; Injectable Drugs; Controlled Release Formulations
- 3) By Functionality: Texturizing Agent; Moisture Retention Agent; Bulking Agent; Emulsifying Agent; Film-Forming Agent
- 4) By Application: Binders And Coating Agents; Disintegrants; Fillers And Extenders; Stabilizers; Thickening Agents
- 5) By End-User: Pharmaceutical Manufacturers; Contract Research Organizations (CROs); Contract Manufacturing Organizations (CMOs); Research And Development Labs; Academic Institutions; Other End-users
- Subsegments:
- 1) By Potato Starch: Modified Potato Starch; Native Potato Starch
- 2) By Corn Starch: Modified Corn Starch; Native Corn Starch
- 3) By Other Types: Rice Starch; Wheat Starch; Tapioca Starch
- Companies Mentioned: Cargill Incorporated; Archer Daniels Midland Company; Ingredion Incorporated; Tereos SCA; Roquette Freres SA.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Pharmaceuticals Native Starch Market Characteristics
3. Pharmaceuticals Native Starch Market Trends And Strategies
4. Pharmaceuticals Native Starch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Pharmaceuticals Native Starch Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pharmaceuticals Native Starch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pharmaceuticals Native Starch Market Growth Rate Analysis
- 5.4. Global Pharmaceuticals Native Starch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pharmaceuticals Native Starch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pharmaceuticals Native Starch Total Addressable Market (TAM)
6. Pharmaceuticals Native Starch Market Segmentation
- 6.1. Global Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Potato Starch
- Corn Starch
- Other Types
- 6.2. Global Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Solid Dosage Forms
- Liquid Dosage Forms
- Topical Formulations
- Injectable Drugs
- Controlled Release Formulations
- 6.3. Global Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Texturizing Agent
- Moisture Retention Agent
- Bulking Agent
- Emulsifying Agent
- Film-Forming Agent
- 6.4. Global Pharmaceuticals Native Starch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Binders And Coating Agents
- Disintegrants
- Fillers And Extenders
- Stabilizers
- Thickening Agents
- 6.5. Global Pharmaceuticals Native Starch Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical Manufacturers
- Contract Research Organizations (Cros)
- Contract Manufacturing Organizations (Cmos)
- Research And Development Labs
- Academic Institutions
- Other End-Users
- 6.6. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Potato Starch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Modified Potato Starch
- Native Potato Starch
- 6.7. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Corn Starch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Modified Corn Starch
- Native Corn Starch
- 6.8. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Rice Starch
- Wheat Starch
- Tapioca Starch
7. Pharmaceuticals Native Starch Market Regional And Country Analysis
- 7.1. Global Pharmaceuticals Native Starch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Pharmaceuticals Native Starch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pharmaceuticals Native Starch Market
- 8.1. Asia-Pacific Pharmaceuticals Native Starch Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pharmaceuticals Native Starch Market
- 9.1. China Pharmaceuticals Native Starch Market Overview
- 9.2. China Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pharmaceuticals Native Starch Market
- 10.1. India Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pharmaceuticals Native Starch Market
- 11.1. Japan Pharmaceuticals Native Starch Market Overview
- 11.2. Japan Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pharmaceuticals Native Starch Market
- 12.1. Australia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pharmaceuticals Native Starch Market
- 13.1. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pharmaceuticals Native Starch Market
- 14.1. South Korea Pharmaceuticals Native Starch Market Overview
- 14.2. South Korea Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pharmaceuticals Native Starch Market
- 15.1. Western Europe Pharmaceuticals Native Starch Market Overview
- 15.2. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pharmaceuticals Native Starch Market
- 16.1. UK Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pharmaceuticals Native Starch Market
- 17.1. Germany Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pharmaceuticals Native Starch Market
- 18.1. France Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pharmaceuticals Native Starch Market
- 19.1. Italy Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pharmaceuticals Native Starch Market
- 20.1. Spain Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pharmaceuticals Native Starch Market
- 21.1. Eastern Europe Pharmaceuticals Native Starch Market Overview
- 21.2. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pharmaceuticals Native Starch Market
- 22.1. Russia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pharmaceuticals Native Starch Market
- 23.1. North America Pharmaceuticals Native Starch Market Overview
- 23.2. North America Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pharmaceuticals Native Starch Market
- 24.1. USA Pharmaceuticals Native Starch Market Overview
- 24.2. USA Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pharmaceuticals Native Starch Market
- 25.1. Canada Pharmaceuticals Native Starch Market Overview
- 25.2. Canada Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pharmaceuticals Native Starch Market
- 26.1. South America Pharmaceuticals Native Starch Market Overview
- 26.2. South America Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pharmaceuticals Native Starch Market
- 27.1. Brazil Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pharmaceuticals Native Starch Market
- 28.1. Middle East Pharmaceuticals Native Starch Market Overview
- 28.2. Middle East Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pharmaceuticals Native Starch Market
- 29.1. Africa Pharmaceuticals Native Starch Market Overview
- 29.2. Africa Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pharmaceuticals Native Starch Market Competitive Landscape And Company Profiles
- 30.1. Pharmaceuticals Native Starch Market Competitive Landscape
- 30.2. Pharmaceuticals Native Starch Market Company Profiles
- 30.2.1. Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Archer Daniels Midland Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Tereos SCA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Roquette Freres SA. Overview, Products and Services, Strategy and Financial Analysis
31. Pharmaceuticals Native Starch Market Other Major And Innovative Companies
- 31.1. AGRANA
- 31.2. Tate & Lyle Public Limited Company
- 31.3. Colorcon Inc.
- 31.4. Grain Processing Corporation
- 31.5. Siam Modified Starch Co. Ltd.
- 31.6. BENEO GmbH
- 31.7. Gulshan Polyols Ltd.
- 31.8. SPAC Starch Products (India) Private Limited
- 31.9. Universal Starch-Chem Allied Ltd.
- 31.10. Sanstar Biopolymers Ltd.
- 31.11. Emsland Group
- 31.12. Hungrana Kft.
- 31.13. Bluecraft Agro Pvt. Ltd.
- 31.14. Visco Starch
- 31.15. Shandong Liujia Pharmaceutical Excipient Co.Ltd.
32. Global Pharmaceuticals Native Starch Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pharmaceuticals Native Starch Market
34. Recent Developments In The Pharmaceuticals Native Starch Market
35. Pharmaceuticals Native Starch Market High Potential Countries, Segments and Strategies
- 35.1 Pharmaceuticals Native Starch Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Pharmaceuticals Native Starch Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Pharmaceuticals Native Starch Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
